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During aortic aneurysm surgery, the myocardium is
subjected to considerable mechanical and biochemical
stresses. The incidence of postoperative myocardial
infarction (MI) after supraceliac clamping for thora-
coabdominal aortic aneurysm (TAAA) surgery is report-
ed to be between 4% and 7%, whereas that for postop-
erative cardiac complications without evidence of
ischemic damage is between 12% and 36%.1-4 These
non-MI cardiac complications may manifest as pul-
monary edema, newly developed arrhythmias, or dimin-
ished cardiac output in the absence of an obvious cause.
The development of these complications after major
surgery may adversely affect recovery in the immediate
postoperative period and is also associated with signifi-
cantly increased risk of cardiovascular death in the long
term.5 Although mechanical stress to the myocardium
can lead to cardiac damage, another possible mechanism
is remote injury as the result of ischemia-reperfusion.
Tissue injury after ischemia-reperfusion is a clini-
cal situation in which excessive oxygen-derived free
radical (ODFR) production is thought to play an
important role, particularly after intestinal ischemia-
reperfusion.6 ODFRs are highly reactive radicals that
can react with any chemical in their environment. To
protect against the destructive effects of ODFR, an
elaborate free radical scavenging system exists. This
antioxidant system is made of specific intracellular
antioxidant enzymes and of free circulating plasma
antioxidants.7 Measurement of changes to the plasma
antioxidant capacity provides an indirect method of
quantifying global oxidative stress.8
One of the main sites of ODFR action is the cell
wall membrane. On exposure to ODFR, the polyun-
saturated fatty acids present in the cell wall undergo
lipid peroxidation.9,10 Lipid peroxidation of cellular
membranes is associated with a multitude of func-
tional changes, ranging from decreased fluidity to
loss of selective permeability and signal transduction.
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Purpose: The purpose of this study was to examine the effects of major aortic surgery and
its associated oxidative stress and injury on the myocardium.
Methods: Plasma from 27 patients who underwent thoracoabdominal aortic aneurysm
(TAAA) repair and 17 patients who underwent infrarenal aortic aneurysm (AAA) repair
was collected at incision, aortic crossclamping, and reperfusion and 1, 8, and 24 hours
thereafter. Samples were assayed for the myocardial specific protein troponin-T, total
antioxidant status, and lipid hydroperoxides. 
Results: Ten patients experienced cardiac dysfunction in the first 24 hours after surgery
(eight patients in the TAAA group and two patients in the AAA group). Immediately
after reperfusion, total antioxidant status levels dropped in all patients with TAAA and
with AAA; this was more marked in patients with TAAA, leading to a significant differ-
ence between the two groups at this time point and for up to 1 hour thereafter (P < .01).
Patients with TAAA showed a sharp rise in lipid hydroperoxide levels immediately after
reperfusion, and levels were significantly higher than in patients with AAA (P = .0007).
In patients with AAA, no significant change in troponin-T was observed throughout the
study period; whereas in patients with TAAA, levels were significantly elevated at 8 and
24 hours after reperfusion (P < .01). Troponin-T levels significantly correlated with
total antioxidant status (r = –0.5) and lipid hydroperoxides (r = 0.78) but not with sys-
tolic blood pressure. 
Conclusion: Supracoeliac aortic crossclamping is associated with a significant release of
the myocardial injury marker troponin-T. This seems to correlate with the severity of
oxidative rather than hemodynamic stresses. Ameliorating oxidative injury during TAAA
surgery may therefore have a cardioprotective effect. (J Vasc Surg 2000;31:742-50.)
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In this study, we evaluated myocardial damage
associated with reperfusion after supraceliac and
infrarenal aortic crossclamping by measuring changes
to the myocardium-specific protein troponin-T (TnT).
This protein is a sensitive and specific marker for
myocardial injury.11,12 We also studied the relationship
between TnT changes and the magnitude of oxidative
stress and oxidative injury as measured by changes to
the total plasma antioxidant status (TPAS) and lipid
hydroperoxide (LHP), respectively.
PATIENTS AND METHODS
With approval by the ethics committee, informed
consent to participate in the study was obtained from
27 patients who were undergoing elective Crawford
types III and IV13 TAAA repair and 17 patients
undergoing elective infrarenal abdominal aneurysm
(AAA) repair. In our institution, Crawford types III
and IV TAAA are repaired with simple supraceliac
aortic crossclamping without shunting or left heart
bypass grafting. Ventricular function in all patients
who underwent elective TAAA surgery was assessed
before the operation by stress echocardiography, as
previously described.14,15 Only patients with no sig-
nificant coronary artery disease (ventricular wall
motion score, 16-18)14 were included in this study.
Physiologic status before and after the operation was
evaluated with the Acute Physiology and Chronic
Health Evaluation II score (APACHE II).16 For the
purpose of this study, postoperative cardiac dysfunc-
tion was identified as the occurrence of one or more
cardiac events, excluding MI. These events included
newly developed arrhythmias (arrhythmias requiring
pharmacologic correction), electromechanical dissoci-
ation (sudden disappearance of an effective arterial
pressure in the presence of adequate electrocardio-
graphic complexes), and cardiac arrest. Patients with
AAA were assessed clinically before the operation, and
all patients underwent preoperative electrocardiogra-
phy. Once deemed clinically fit for surgery, patients
with AAA had no further cardiac investigations for
occult coronary artery disease. 
After induction of anesthesia, a radial arterial line
was inserted, and arterial samples were collected at
incision, on aortic clamping (supraceliac in patients
with TAAA and infrarenal in patients with AAA), on
reperfusion (splanchnic in patients with TAAA and
limb in patients with AAA), and at 1, 8, and 24 hours
after reperfusion. Plasma was separated immediately,
snap frozen, and later assayed for changes to TPAS
with the use of the Randox assay17 (Randox
Laboratories, Co.Antrim, UK), for changes to LHP
with the use of the Peroxoquant assay18 (Pierce &
Warriner, Chester, UK), and for the myocardial spe-
cific protein TnT19 (Boheringer Mannheim, Lewes,
UK). After the operation, patients with TAAA were
admitted to the intensive therapy unit although most
of the patients with AAA were admitted to a high-
dependency unit. The monitoring modalities in these
two units are identical; the only difference is that the
high-dependency unit does not have the facility for
mechanical ventilatory support. All patients received
continuous electrocardiography and arterial pressure
and central venous pressure monitoring after the
operation. In addition, patients with TAAA had pul-
monary artery pressures monitoring. 
Normality tests were performed on all data. For
nonparametric data, the median figures were used,
and statistical analysis between groups was per-
formed with the Mann-Whitney U test corrected for
ties and for repeated measurements (Bonferroni).
Statistical analysis between time points within the
same group was performed with the Wilcoxon
signed ranks test. The Student t test and Fisher’s
exact test were used in risk factor analysis. Data relat-
ed to arterial pressures, heart rates, and APACHE II
score were parametric and are presented as mean and
were analyzed with the analysis of variance test.
Statistical significance was assumed when probabili-
ty values were less than .01 for all tests.
RESULTS
In patients with TAAA, the median preoperative
stress ventricular wall motion score was 16 (range, 16-
18) in both groups of patients with and without post-
operative cardiac dysfunction. Table I shows the
demographic data for the patients included in this
study. Patients with TAAA had a median age of 69
years (range, 50-80 years), whereas patients with AAA
had a median age of 76 years (range, 53-84 years; P =
.005). Patients with TAAA had significantly longer
distal (lower limb) ischemia time and had significant-
ly more blood transfusions between operations. Table
II shows the distribution of cardiac events in all
patients. Of the 44 patients studied, 10 patients expe-
rienced the development of cardiac dysfunction in the
first 24 hours after surgery (eight patients in the
TAAA group and two patients in the AAA group).
Another two patients in the TAAA group experienced
the development of transmural MI after the operation
and were excluded from the study. The median time
of cardiac complication occurrence was 4 hours
(range, 1-24 hours) postperfusion.
The incidence of major postoperative complica-
tions (death, renal failure requiring hemofiltration,
and respiratory failure requiring ventilation for 4 or
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more days) was 87.5% in the group with cardiac dys-
function and 47% in the group with no complica-
tions (P = .03, Fisher’s exact test). Table III shows
the distribution of these complications.
Table IV shows the demographic and risk factor
analysis of patients with TAAA, based on the pres-
ence of postoperative cardiac dysfunction. No signif-
icant difference in ischemia time or other risk factors
was found between the two groups. 
Systemic and arterial pressures and heart rate.
There was no significant difference between patients
with TAAA with or without cardiac complications in
any of these parameters at any of the time points. In
all, eight patients with TAAA required inotrope sup-
port immediately after splanchnic reperfusion. Three
of these patients were in the group with cardiac
complications. 
APACHE II scores. Fig 1 shows the APACHE
II scores for patients with TAAA, based on their car-
diac outcome. There was no significant difference
between preoperative scores and scores recorded on
admission to the intensive care unit between these
two groups of patients.
However, patients who went on to experience
the development of cardiac dysfunction had signifi-
cantly higher scores from day 1 to day 4 after the
operation. Most patients who had no cardiac com-
plications were discharged from the intensive care
unit after 4 days.
TPAS. TPAS levels (Fig 2) were not significant-
ly different between patients with TAAA and
patients with AAA at the incision and aortic cross-
clamping time points. Immediately after reperfusion,
a drop in TPAS level was observed in both groups;
this was more marked in patients with TAAA, lead-
ing to a significant difference between the two
groups at this time point (P = .0005). At 1 hour
after reperfusion, levels were still significantly lower
in patients with TAAA (P = .005). Recovery of
TPAS levels occurred between the 1 and 8 hours
after reperfusion time points, and no significant dif-
ference between the two groups of patients was
observed at 8 and 24 hours after reperfusion. 
Table I. Demographic and risk factor analysis of
patients included in the study
Variable TAAA AAA P value
Patients (n) 27 17
Women/men (n) 9/18 5/12
Median age (y; range) 69 (50-80) 76 (53-84) .005*
Crawford type III (n) 15 —
Crawford type IV (n) 12 —
Smoker (n) 10 6 .6†
Hypertension (n) 15 8 .5†
Median visceral ischemia 43 (11-122) —
time (min; range)
Median distal ischemia 68 (30-160) 52 (30-115) .01*
time (min; range)





Table II. Distribution of postoperative cardiac
complications
TAAA AAA 
Cardiac event (n = 27 patients) (n = 17 patients)
MI (n) 2 —
Cardiac arrest/electro- 4 —
mechanical dissociation (n)
Arrhythmia* (n) 4 2
TOTAL (n) 10 2
*All were atrial fibrillation.
Table III. Distribution of major complications in
patients with TAAA based on cardiac outcome
With cardiac Without cardiac 
dysfunction dysfunction
Cardiac outcome (n = 8) (n = 17) P value*
Respiratory failure 4 3 .1
Renal failure 4 5 .2
Death 4† 2‡ .05
*x2 Test.
†Two patients died of cardiac arrest, and two patients died of
coagulopathy.
‡Both patients died of coagulopathy.
Table IV. Demographic and risk factor analysis of
patients with TAAA based on the development of
cardiac dysfunction
Without With
Variable dysfunction dysfunction P value
Patients (n) 17 8
Median age (y; range) 70 (62-80) 64 (50-76) .1*
Median visceral ischemia 44 (11-68) 43 (18-122) .42*
time (min; range)
Median distal ischemia 72.5 (46-148) 84 (40-160) .26*
time (min; range)
Median intraoperative blood 10 (2-35) 11.5 (6-19) .82*
transfused (units; range)
Smoker (n) 6 4 .4†
Hypertension (n) 8 7 .6†
*Two independent sample t-test; two-tailed P value.
†Fisher exact test.
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Fig 2. TPAS in patients with TAAA and in patients with AAA. Data represent median,
(interquartile range).
Fig 1. Mean APACHE II score values in patients with TAAA based on their cardiac outcome.
Eight patients experienced postoperative cardiac events, and 17 patients did not. *P < .01,
analysis of variance.
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Plasma LHP. Fig 3 shows the changes in LHP
levels in patients with TAAA and in patients with
AAA. Levels were also not statistically significant
between the two groups at incision and crossclamp-
ing time points. Immediately on reperfusion, LHP
levels showed a sharp rise in patients with TAAA,
and a significant difference between the two groups
was observed at this time point (P = .0005). 
TnT. Fig 4 shows TnT changes in patients with
TAAA and in patients with AAA. At incision, the
median TnT value was 0.01 ng/mL (range, 0.0-
0.02 ng/mL) in both groups. In patients with AAA,
no significant change in TnT levels was observed
throughout the study period; whereas in patients
with TAAA, TnT levels increased to 0.07 ng/mL
(0.03-0.08 ng/mL) at 8 hours and 0.04 ng/mL
(0.02-0.1 ng/mL) at 24 hours after reperfusion (P
< .01, both points). Values in patients with TAAA
were significantly higher than those values in
patients with AAA at 8 and 24 hours after reperfu-
sion (P < .01, both points). 
Fig 5 shows the changes of TnT levels in patients
with TAAA, based on the presence or absence of car-
diac dysfunction. In the eight patients with TAAA
who experienced postoperative cardiac dysfunction,
TnT levels showed a stepwise elevation reaching a
maximum of 0.1 ng/mL (0.03-0.21 ng/mL) at 24
hours after reperfusion. TnT levels in this group
were significantly higher than those levels in patients
without cardiac complications at 1, 8, and 24 hours
after reperfusion (P < .01, all time points). In the
two patients with TAAA who were excluded from
the study and who sustained MI, peak TnT levels
were nearly tenfold higher than those levels mea-
sured in patients with cardiac dysfunction. 
Spearman’s linear correlation analysis revealed a
significant correlation between peak TnT levels and
each of the lowest TPAS (r = –0.5; P = .01) and peak
LHP levels (r = 0.57; P = .01). There was no signif-
icant correlation between TnT levels and duration of
splanchnic or total ischemia times. With the use of
the same analysis, there was a significant correlation
between visceral ischemia time and LHP levels (r =
5.1; P = .01) but not with TPAS levels (r = –0.2; P
= .1). TPAS baseline levels of less than 1.4
mmol/mL correlated significantly with the develop-
ment of postoperative complications (P = .01, Fisher
exact test).
Multiple regression analysis after correction for
ischemia time and blood transfusion showed no cor-
relation between peak TnT levels and lowest record-
ed systolic blood pressure (lowest pressure reading
lasted for 10 minutes or more during and after
surgery; r = –0.03; P = .9). However, a significant
Fig 3. LHP changes in patients with TAAA and in patients with AAA. Data are presented as
median (interquartile range).
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Fig 4. Changes in plasma TnT levels in 25 patients with TAAA (after two patients with post-
operative MI were excluded) and in 17 patients with AAA. Data are presented as median.
Fig 5. Median TnT levels are shown in eight patients who experienced cardiac dysfunction
and in 17 patients who did not (two patients with TAAA with transmural MI were excluded). 
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correlation existed between peak TnT levels and
minimum TPAS levels (r = –0.5; P = .01) and with
peak LHP levels (r = 0.78; P = .001). 
DISCUSSION
In this study, we demonstrated that supraceliac
aortic crossclamping during surgery for TAAAs is
associated with significant elevation of the myocardi-
um injury marker TnT. TnT level changes in the 17
patients with AAA with infrarenal aortic crossclamp-
ing were minimal and nonsignificant, thus support-
ing the clinical observation that this type of surgery
does not carry the same risk of myocardial injury.
Furthermore, patients with TAAA who after the
operation went on to experience signs of myocardial
dysfunction had significantly higher levels of TnT
than those patients who did not experience myocar-
dial dysfunction.
This observation is similar to that reported by
Lee et al20 in patients who underwent noncardiac
surgery. They found that a postoperative rise in TnT
levels correlates significantly with the development
of postoperative non-MI cardiac complications.
Although the rise in TnT level in our patients with
supraceliac aortic crossclamping was significant
(even in those who experienced postoperative car-
diac dysfunction), levels remained less than those
seen in patients with transmural MI.21-23
Although it is not possible to exclude myocardial
cell death as the cause of raised TnT levels in our
patients with TAAA without histologic examination,
a growing body of evidence now supports the exis-
tence of a clinical entity of cardiac injury that is asso-
ciated with an intermediate rise in TnT levels in the
absence of transmural MI or ischemic electrocardio-
graphic changes. This entity comprises patients with
angina, microinfarcts, and myocardial ischemia-
reperfusion injury.24-30 In this group of patients, the
moderate rise in TnT level is due to cell-wall damage
with subsequent release of the unbound cytosolic
TnT.31 Although the risk of subsequent MI and
death is estimated to be 10.5% in patients with angi-
na and an intermediate rise in TnT level (0.06-0.18
ng/mL),32 such risks in noncardiac surgical patients
with a similar rise in TnT level remain unknown.
Yeager et al33 attempted to quantify such risks by
following up 8 vascular surgical patients with bio-
chemical MI, as detected by creatine kinase-MB.
Although they showed no significant long-term
effects in this group, they agreed that their numbers
were too small to produce any firm conclusions. 
In our group of patients with TAAA with cardiac
complications, myocardial dysfunction occurred
during or a few hours after surgery, and the associ-
ated increase in TnT level was observed as early as 1
hour after reperfusion. Because the presence of sig-
nificant myocardial ischemia or significant organ
impairment between patients with TAAA who expe-
rienced cardiac dysfunction and those who did not
was excluded before the operation, it is unlikely that
the myocardial injury in these patients was due to
primary myocardial ischemia. This assumption is also
supported by the fact that the magnitude of TnT
level changes in the two patients with MI was 10
times more than that seen in the cardiac dysfunction
group. It is therefore likely that other factors such as
mechanical stresses and remote ischemia-reperfusion
injury during and after surgery have contributed to
the cardiac injury observed. 
In patients with supraceliac clamping and in the
few minutes before aortic clamping, vasodilator drugs
such as sodium nitroprusside and glyceryl trinitrate
are given to achieve a controlled drop in peripheral
vascular resistance and cardiac output in the anticipa-
tion of the sudden rise in peripheral resistance on aor-
tic crossclamping. Immediately after declamping, the
drop in peripheral vascular resistance and blood pres-
sure may be severe and prolonged, thus requiring 
an infusion of inotropes such as adrenaline and 
noradrenaline to improve cardiac contractility and to
increase peripheral resistance. 
Although these mechanical and pharmacologic
stresses to the cardiovascular system may correlate with
the development of postoperative MI as previously
shown by Hollier et al,2 the correlation between these
changes and the development of postoperative cardiac
dysfunction has not been previously studied. In this
study, we were unable to demonstrate a correlation
between blood pressure changes and TnT level. We
believe that this may be because the changes in blood
pressure alone, as suggested by Hollier et al, may not
adequately reflect the severity of mechanical stresses in
these patients. However, correlating between cardiac
output, peripheral vascular resistance, and the devel-
opment of postoperative cardiac dysfunction may be a
more accurate method. 
The other possible explanation of the myocardial
injury in these patients is remote ischemia-reperfu-
sion injury after aortic declamping. If powerful
enough, the burst of ODFR after reperfusion may
overwhelm the natural antioxidant defenses and ini-
tiate a cascade of events that lead to proinflammato-
ry cytokine production with local or remote cell
injury and death.10,34
Unlike patients with AAA, patients with TAAA
sustained a more severe oxidative stress and free rad-
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ical injury, mainly because of splanchnic ischemia-
reperfusion. This is shown by the more significant
changes to LHP level immediately after splanchnic
reperfusion. Although LHP and TPAS levels corre-
lated significantly with ischemia time, TnT levels did
not. This lack of correlation indicates that myocar-
dial injury in these patients is not a function of
absolute ischemia time but rather the ability of the
antioxidant defensive mechanisms to cope with this
ischemia. In an animal model, Horton and White35-
37 demonstrated that intestinal ischemia even for a
brief period followed by reperfusion can lead to pro-
longed and significant cardiac contractile dysfunc-
tion and to significant LHP of cardiac cell mem-
branes. They attributed these changes to oxygen free
radial generation by intestinal xanthine oxidase.
Ischemia-reperfusion of splanchnic organs other
than the intestine can also lead to cardiac injury.
Pretto38 demonstrated that isolated hepatic
ischemia-reperfusion can lead to a direct increase in
coronary resistance and a drop in coronary blood
flow and heart rate. The combined effect of intesti-
nal and hepatic ischemia-reperfusion during TAAA
surgery may therefore lead to myocardial cell dam-
age. It remains difficult to ascertain a causal rela-
tionship between the higher incidence of major
complications in patients with TAAA with myocar-
dial dysfunction and the myocardial damage in these
patients. It is more likely that the two are the result
of a more global ischemia-reperfusion injury. 
In summary, our data suggest that clamping of
the aorta above the celiac vessels and without bypass
grafting is associated with myocardial injury. This
injury correlates with the severity of oxidative stress
and with poor outcome. Patients undergoing AAA
surgery are less likely to sustain such stresses and
subsequently showed no evidence of myocardial
damage during the operation. Measures to attenuate
splanchnic ischemia and possibly oxidative stresses
(such as the use of selective mesenteric shunting39
and antioxidant augmentation) may therefore have a
cardioprotective effect in patients with TAAA.
Although mechanical stresses during this type of
surgery may contribute to the sustained myocardial
injury, these stresses remain invariably inevitable
because of the nature of aortic surgery itself.
REFERENCES 
1. Gilling-Smith GL, Worswick L, Knight PF, Wolfe JHN,
Mansfield AO. Surgical repair of thoracoabdominal aortic
aneurysm: 10 years experience. Br J Surg 1995;82;624-9.
2. Hollier LH, Symmonds JB, Pairolero PC, Cherry KJ, Hallet
JW, Gloviczki P. Thoracoabdominal aortic aneurysm repair:
analysis of postoperative morbidity. Arch Surg 1988;123:871-5.
3. Cox GS, O’Hara PJ, Hertzer NR, Piedmonte MR, Krajewski
LP, Beven EG. Thoracoabdominal aneurysm repair: a repre-
sentative experience. J Vasc Surg 1992;15:780-8.
4. Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ.
Experience with 1509 patients undergoing thoracoabdomi-
nal aortic operations. J Vasc Surg 1993;17:357-70.
5. Charlson M, Peterson J, Szatrowski TP, MacKenzie R, Gold
J. Long-term prognosis after peri-operative cardiac complica-
tions. J Clin Epidemiol 1994;47:1389-400.
6. Granger DN, Rutili G, McCord JM. Superoxide radicals in
feline intestinal ischemia. Gastroenterology 1981;81:22-9.
7. Halliwell B. Reactive oxygen species in living systems: source,
biochemistry, and role in human disease. Am J Med
1991;91(suppl):14S-22S.
8. Leff JA, Parsons PE, Day CE, et al Serum antioxidants as pre-
dictors of adult respiratory distress syndrome in patients with
sepsis. Lancet 1993;341:777-80.
9. Halliwell B, Gutteridge JMC. Role of free radicals and cat-
alytic metal ions in human disease: an overview. Methods
Enzymol 1990;186:1-85.
10. Freeman BA, Crapo JD. Biology of disease, free radicals and
tissue injury. Lab Invest 1982;47:412-26.
11. Mair J, Dienstl F, Puschendorf B. Cardiac troponin T in the
diagnosis of myocardial injury. Crit Rev Clin Lab Sci
1992;29:31-57.
12. Muller Bardorff M, Freitag H, Scheffold T, Remppis A,
Kubler W, Katus HA. Development and characterization of a
rapid assay for bedside determinations of cardiac troponin T.
Circulation 1995;92:2869-75.
13. Crawford ES, Snyder DM, Cho GC, Roehm JOF. Progress
in the treatment of thoracoabdominal and abdominal aortic
aneurysms involving celiac, superior mesenteric, and renal
arteries. Ann Surg 1978;188:404-22.
14. Sawada SG, Segar DS, Ryan T, et al. Echocardiographic
detection of coronary artery disease during dobutamine infu-
sion. Circulation 1991;83:1605-14.
15. Bourdillon PD, Broderick TM, Sawada SG, et al. Regional wall
motion index for infarct and non-infarct regions after reperfu-
sion in acute myocardial infarction: comparison with global
wall motion index. J Am Soc Echocardiogr 1989;2:398-407.
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE.
APACHE II: a severity of disease classification system. Crit
Care Med 1985;13:818-29.
17. Rice-Evans C, Nicholas-Miller J. Total antioxidant status in
plasma and body fluids. Methods Enzymol 1994;234:279-93.
18. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP. Measurement
of plasma hydroperoxide concentrations by the ferrous oxida-
tion-xylenol orange assay in conjunction with triphenylphos-
phine. Ann Biochem 1994;220:403-9.
19. Katus HA, Rempis A, Neuman FJ, et al. Diagnostic efficien-
cy of troponin-T measurement in acute myocardial infarc-
tion. Circulation 1991;83:902-12.
20. Lee TH, Thomas EJ, Ludwig LE, et al. Troponin-T as a
marker for myocardial ischemia in patients undergoing major
non-cardiac surgery. Am J Cardiol 1996;77:1031-6.
21. Abe S, Arima S, Yamashita T, et al. Early assessment of reper-
fusion therapy using cardiac troponin T. J Am Coll Cardiol
1994;23:1382-9.
22. Collinson PO, Moseley D, Stubbs PJ, Carter GD. Troponin
T for the differential diagnosis of ischemic myocardial dam-
age. Ann Clin Biochem 1993;30:11-6.
23. Alonsozana GL, Christenson RH. The case for cardiac tro-
ponin T: marker for effective risk stratification of patients
with acute cardiac ischemia. Clin Chem 1996;42:803-8.
JOURNAL OF VASCULAR SURGERY
750 Hafez et al April 2000
24. Hake U, Schmid FX, Iversen S, et al. Troponin-T, a reliable
marker of perioperative myocardial infarction? Eur J
Cardiothorac Surg 1993;7:628-33.
25. Gerhardt W, Ljungdahl L, Herbert AK. Troponin-T and CK
MB (mass) in early diagnosis of ischemic myocardial injury:
the Helsingborg Study 1992. Clin Biochem 1993;26:231-40.
26. Collinson PO, Moseley D, Stubbs PJ, Carter GD. Troponin
T for the differential diagnosis of ischemic myocardial dam-
age. Ann Clin Biochem 1993;30:11-6.
27. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M.
Prospective study of the role of cardiac troponin T in patients
admitted with unstable angina. Br Med J 1996;313:262-4.
28. Ravkilde J, Nissen H, Mickley H, Andersen PE, Thayssen P,
Horder M. Cardiac troponin T and CK-MB mass release after
visually successful percutaneous transluminal coronary angio-
plasty in stable angina pectoris. Am Heart J 1994;127:13-20.
29. Machler H, Gombotz H, Sabin K, Metzler H. Troponin T as
a marker of perioperative myocardial cell damage. Adv
Pharmacol 1994;31:63-73.
30. Mair P, Mair J, Koller J, Wieser C, Talasz H, Puschendorf B.
Cardiac troponin T release in multiply injured patients.
Injury 1995;26:439-43.
31. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler
W. Intracellular compartmentation of cardiac troponin T and
its release kinetics in patients with reperfused and nonreper-
fused myocardial infarction. Am J Cardiol 1991;67:1360-7.
32. Lindahl B, Venge P, Wallentin L. Relation between troponin
T and the risk of subsequent cardiac events in unstable coro-
nary artery disease: the FRISC study group. Circulation
1996;93:1651-7.
33. Yeager RA, Moneta GL, Edwards JM, Taylor LM Jr,
McConnell DB, Porter JM. Late survival after perioperative
myocardial infarction complicating vascular surgery. J Vasc
Surg 1994;20,4:598-606.
34. Bast A, Haenen GR, Doelman CA. Oxidants and antioxidants:
state of the art. Am J Med September 1991;91 (suppl):2s-13s.
35. Horton JW, White DJ. Cardiac contractile injury after intesti-
nal ischemia-reperfusion. Am J Physiol 1991;261(Heart Circ
Physiol):H1164-70. 
36. Horton JW, White DJ. Lipid peroxidation contributes to car-
diac deficits after ischemia and reperfusion of the small
bowel. Am J Physiol 1993;264(suppl):H1686-92.
37. Horton JW, White DJ. Free radical scavengers prevent
intestinal ischemia-reperfusion mediated cardiac dysfunction.
J Surg Res 1993;55:282-9
38. Pretto EA. Cardiac function after hepatic ischemia-anoxia
and reperfusion injury: a new experimental model. Crit Care
Med 1991;19:1188-94.
39. Cambria RP, Davison JK, Giglia JS, Gertler JP. Mesenteric
shunting decreases visceral ischemia during thoracoabdomi-
nal aneurysm repair. J Vasc Surg 1998;27:745-74.
Submitted Apr 7, 1999; accepted Jul 15, 1999.
Don’t miss a single issue of the journal!  To ensure prompt service when you change your address,
please photocopy and complete the form below. 
Please send your change of address notification at least six weeks before your move to ensure continued ser-
vice.  We regret we cannot guarantee replacement of issues missed due to late notification.
JOURNAL TITLE:
Fill in the title of the journal here.
OLD ADDRESS:
Affix the address label from a recent issue of the journal here.
COPY AND MAIL THIS FORM TO: OR FAX TO: OR PHONE:
Journal Subscription Services 314-432-1158 1-800-453-4351
Mosby, Inc Outside the US, call
11830 Westline Industrial Dr 314-453-4351
St Louis, MO  63146-3318
NEW ADDRESS:




Send us your new address at least six weeks aheadO N THE MOVE?
